Eli Lilly's Alzheimer's drug has been rejected for use on the NHS in England, according to a recent report. The decision comes after an independent review by the National Institute for Health and Care Excellence (NICE). No further details have been disclosed regarding the reasons behind the rejection.

Source: https://www.bloomberg.com/news/articles/2024-10-23/eli-lilly-alzheimer-s-drug-rejected-for-nhs-use-in-england